UNSPSC 51191536: Chlormerodrin

This classification denotes a loop diuretic with the molecular formula C5H11ClHgN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 99T5TWO621, chemically known as urea, (3-(chloromercurio)-2-methoxypropyl)- but generally known as chlormerodrin, which bears US NIH Compound Identifier 2716. European Medicines Agency schedules Chlormerodrin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06184MIG. The term CHLORMERODRIN is an International Non-Proprietary Name.

UNSPSC 51191536 Chlormerodrin is a Commodity code that encompasses pharmaceutical and chemical supply procurement for state and local government operations, though recent opportunities posted under this code show divergence from the nominal chlormerodrin classification. The City of Meriden issued an IFB (B02715) in July 2026 for sodium bisulfite chemical supply to its Water Pollution Control Facility, reflecting municipal water treatment operations; separately, the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, posted an RFP (S1070000015802) due March 26, 2026 for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities, including Oregon. The code sees activity from municipal water departments and state-level cooperative purchasing vehicles coordinating drug supply across multiple jurisdictions and wholesalers. Issuing bodies include city purchasing offices (such as Meriden, Connecticut) and state procurement departments operating multi-state cooperative purchasing agreements; MMCAP's model brings together state agencies and participating local health systems under a single vendor management framework.

Geographic activity spans the Upper Midwest (Minnesota as the administering state) and the Northeast (Connecticut), with MMCAP participation extending to Oregon. The Meriden IFB required bids by July 29, 2026 for sodium bisulfite under firm-price terms, with performance and payment bonds mandated and insurance requirements including $1,000,000–$2,000,000 General Liability. The MMCAP RFP required vendor certification of current Good Manufacturing Practices compliance and Drug Supply Chain Security Act adherence, mandated maintenance of relationships with at least two of three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, Morris & Dickson), and weighted price competitiveness at 75 percent of evaluation score; vendors were required to submit product data including NDC codes, UPCs, and manufacturing locations, with the resulting awards effective July 1, 2026. Both opportunities indicate ongoing demand for commodity chemical and pharmaceutical supply among municipal utilities and state health procurement, though the code's recent posting mix suggests broader application than the nominal chlormerodrin category alone.